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SUMMARY. The objective of carrying out this research work was to investigate the effect of chirality on
stereospecific dissolution of omeprazole enantiomers from various marketed racemic omeprazole prod-
ucts. Omeprazole is used for the treatment of gastro-duodenal ulcers and symptomatic gastro-oesophageal
reflux. Dissolution of various marketed products was performed using USP type I apparatus in 0.1 N HCl
for 2 h and in pH 6.8 phosphate buffer for 1 h at 100 rpm. The separation of enantiomers was done using a
chiral HPLC method on CHIRAL AGP column (100 x 4.6 mm i.d.). The wavelength for UV detection was
set at 210 nm. The mobile phase was 10 mM phosphate buffer with 5 % acetonitrile adjusted to pH 6.5 at
a flow rate of 0.9 ml min-1 with an injector valve fitted to a 50 μL volume sample loop. The retention times
for R and S enantiomers of omeprazole were 5 and 7.5 min, respectively. The dissolution of S enantiomer
of Ocid-20 and Omee was found to be significantly more compared to their R enantiomer at 5 and 10 min
dissolution time points after which there was no stereospecific discrimination in the dissolution. From the
S/R ratios of different racemic omeprazole marketed products it was concluded that at 5 and 10 min disso-
lution time points there was a stereospecific drug release between the S and R enantiomers  with the
brands Ocid-20 and Omee (p < 0.05) but no stereospecificity was observed with Omez-20 (p > 0.05).
